Smith, A. U., Lancet, ii, 910 (1950). Sloviter, H. A., Lancet, i, 823 (1951). Mollison, P. L., and Sloviter, H. A., Lancet, ii, 862 (1951).

Alexion, AstraZeneca Rare Disease has received the US Food and Drug Administration's (FDA) approval for Voydeya (danicopan) as an add-on therapy to treat extravascular haemolysis (EVH) in adults ...

Danicopan (ALXN2040) has shown its value as an add-on treatment for paroxysmal nocturnal haemoglobinuria (PNH) who experience extravascular haemolysis (EVH) – breakdown of red blood cells in the ...